Let's see if this forecasted upswing in demand in 2022 translates to higher revenues and profit over the next two or three quarters.
All the Covid related hurdles such as supply chain restraints and increased shipping costs have been very detrimental to their business model. If they have been able to rectify some of those issues and are also expecting an upswing in demand then there might be some hope for the company to improve its balance sheet throughout the year.
Roe v Wade court decision. US will ban abortion and thus need more condom imports from Malaysia. Obviously this is a bull case for this company since it is one of the biggest producers and has no ESG issues. Overweight on Karex
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....